MUVCADO
DEAD

Serial Number

98264921

Owner

Reneo Pharmaceuticals, Inc.

Attorney

Brandon P. Leahy

Filing Date

Nov 10, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MUVCADO Trademark

Serial Number: 98264921

MUVCADO is a trademark filed by Reneo Pharmaceuticals, Inc. on November 10, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Reneo Pharmaceuticals, Inc. (4 trademarks)

Irvine, CA 92612

Entity Type: 03

Trademark Details

Filing Date

November 10, 2023

Registration Date

Not Registered

Published for Opposition

July 23, 2024

Goods & Services

Pharmaceutical preparations for the treatment and prevention of mitochondrial diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders; anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of liver and kidney diseases and disorders; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthma; pharmaceutical preparations for the prevention and treatment of fibrosis

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 21, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 21, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 17, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 20, 2024 CNSA
ASSIGNED TO EXAMINER
Jun 18, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 13, 2023 NWOS
NEW APPLICATION ENTERED
Nov 14, 2023 NWAP